Michael Giehl

479 total citations
16 papers, 364 citations indexed

About

Michael Giehl is a scholar working on Spectroscopy, Pharmacology and Oncology. According to data from OpenAlex, Michael Giehl has authored 16 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Spectroscopy, 4 papers in Pharmacology and 3 papers in Oncology. Recurrent topics in Michael Giehl's work include Analytical Chemistry and Chromatography (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Michael Giehl is often cited by papers focused on Analytical Chemistry and Chromatography (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Michael Giehl collaborates with scholars based in Germany, United States and France. Michael Giehl's co-authors include Wolfgang Gowin, David Taylor, Sahar Mohsin, Thorfinnur Gunnlaugsson, T. C. Lee, Fergal J. O’Brien, Raman Parkesh, David Czock, Jörn Rittweger and Dieter Felsenberg and has published in prestigious journals such as Clinical Pharmacokinetics, Nephrology Dialysis Transplantation and Computer Methods and Programs in Biomedicine.

In The Last Decade

Michael Giehl

16 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Giehl Germany	10	103	62	61	58	54	16	364
Monika Seifert United Kingdom	15	28 0.3×	105 1.7×	33 0.5×	91 1.6×	61 1.1×	37	667
Wolfgang Withold Germany	12	87 0.8×	102 1.6×	8 0.1×	17 0.3×	58 1.1×	23	394
Ding Xu China	11	14 0.1×	98 1.6×	43 0.7×	92 1.6×	24 0.4×	66	436
Ji‐Hoon Choi South Korea	9	10 0.1×	36 0.6×	14 0.2×	37 0.6×	49 0.9×	42	335
Arun Gupta United States	9	48 0.5×	83 1.3×	52 0.9×	44 0.8×	4 0.1×	30	327
Mustafa Argun Türkiye	9	56 0.5×	52 0.8×	49 0.8×	60 1.0×	10 0.2×	46	353
Satoshi Shibata Japan	13	24 0.2×	90 1.5×	18 0.3×	385 6.6×	11 0.2×	58	594
Zhiwei Xu China	15	14 0.1×	118 1.9×	18 0.3×	73 1.3×	7 0.1×	29	528
Soham Mukherjee India	12	39 0.4×	53 0.9×	35 0.6×	98 1.7×	5 0.1×	52	433
Vikas Bhushan United States	8	8 0.1×	138 2.2×	11 0.2×	112 1.9×	142 2.6×	30	568

Countries citing papers authored by Michael Giehl

Since Specialization

Citations

This map shows the geographic impact of Michael Giehl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Giehl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Giehl more than expected).

Fields of papers citing papers by Michael Giehl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Giehl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Giehl. The network helps show where Michael Giehl may publish in the future.

Co-authorship network of co-authors of Michael Giehl

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Giehl. A scholar is included among the top collaborators of Michael Giehl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Giehl. Michael Giehl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Fabarius, Alice, Michael Giehl, A. E. J. L. Kramer, et al.. (2008). Centrosome aberrations and G1 phase arrest after in vitro and in vivo treatment with the SRC/ABL inhibitor dasatinib. Haematologica. 93(8). 1145–1154. 35 indexed citations

Fabarius, Alice, Claudia Haferlach, M. C. Muller, et al.. (2007). Dynamics of cytogenetic aberrations in Philadelphia chromosome positive and negative hematopoiesis during dasatinib therapy of chronic myeloid leukemia patients after imatinib failure. Haematologica. 92(6). 834–837. 29 indexed citations

Rittweger, Jörn, et al.. (2004). Adjusting for the partial volume effect in cortical bone analyses of pQCT images.. PubMed. 4(4). 436–41. 56 indexed citations

Lee, T. C., Sahar Mohsin, David Taylor, et al.. (2003). Detecting microdamage in bone. Journal of Anatomy. 203(2). 161–172. 155 indexed citations

Keller, Ferdinand, et al.. (2002). PK-PD curve-fitting problems with the Hill equation? Try one of the 1-exp functions derived from Hodgkin, Douglas or Gompertz. International Journal of Clinical Pharmacology and Therapeutics. 40(1). 23–29. 9 indexed citations

Prohaska, Steffen, Hans‐Christian Hege, Michael Giehl, & Wolfgang Gowin. (2002). Visual analysis of trabecular bone structure.. PubMed. 9(1). P171–2. 2 indexed citations

Czock, David, Michael Giehl, & Frieder Keller. (2000). A Concept for Pharmacokinetic- Pharmacodynamic Dosage Adjustment in Renal Impairment. Clinical Pharmacokinetics. 38(4). 367–375. 8 indexed citations

Giehl, Michael, et al.. (1999). Pharmacokinetics and pharmacodynamics of insulin Lispro compared with regular insulin in haemodialysis patients with diabetes mellitus. Nephrology Dialysis Transplantation. 14(suppl 4). 5–6. 18 indexed citations

Keller, Frieder, et al.. (1998). Standardized structure and modular design of a pharmacokinetic database. Computer Methods and Programs in Biomedicine. 55(2). 107–115. 10 indexed citations

10.

Keller, Frieder, et al.. (1998). Relationship between pharmacokinetic half-life and pharmacodynamic half-life in effect-time modeling.. PubMed. 36(3). 168–75. 4 indexed citations

11.

Giehl, Michael, et al.. (1996). Structured Data Entry for Reliable Acquisition of Pharmacokinetic Data. Methods of Information in Medicine. 35(3). 261–264. 4 indexed citations

12.

Czock, David & Michael Giehl. (1995). Aminoglycoside pharmacokinetics and -dynamics: a nonlinear approach.. PubMed. 33(10). 537–9. 11 indexed citations

13.

Keller, Frieder, et al.. (1994). Vancomycin Dosing in Haemodialysis Patients and Bayesian Estimate of Individual Pharmacokinetic Parameters. The International Journal of Artificial Organs. 17(1). 19–26. 9 indexed citations

14.

Keller, Frieder, et al.. (1993). Nonparametric Meta-Analysis of Published Data on Kidney-Function Dependence of Pharmacokinetic Parameters for the Aminoglycoside Netilmicin. Clinical Pharmacokinetics. 25(1). 71–79. 9 indexed citations

15.

Keller, Frieder, et al.. (1993). Nonlinear kinetics and the 1-exp function in nephropharmacology. European Journal of Clinical Pharmacology. 44(S1). S27–S30. 1 indexed citations

16.

Keller, Flavio & Michael Giehl. (1990). Saturation-type exponential function with a deceleration term for calculating nonlinear kinetics. Die Naturwissenschaften. 77(9). 435–436. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact